Intracellular ISG15 has been shown to promote the expression of MHC class I complexes in breast cancer cells, while secreted ISG15 has been shown to exhibit anti-tumor activities by inducing NK cell proliferation and migration towards tumor cells and the release of IFN-γ from lymphocytes (90, 95, 96). The gene discussed is ISG15; the disease is neoplasm.